Smruthi Organics Limited

Equities

SMRUTHIORG6

INE172E01011

Pharmaceuticals

Market Closed - Bombay S.E. 06:00:56 2024-05-21 am EDT 5-day change 1st Jan Change
165.9 INR -3.49% Intraday chart for Smruthi Organics Limited -1.28% -4.38%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Smruthi Organics Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024 CI
Smruthi Organics Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI
Smruthi Organics Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023 CI
Smruthi Organics Limited Approves Dividend for the Year Ended 31 March 2023 CI
Smruthi Organics Limited Reports Earnings Results for the First Quarter Ended June 30, 2023 CI
Smruthi Organics Limited Proposes Dividend for the Year Ended 31St March, 2023 CI
Smruthi Organics Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023 CI
Smruthi Organics Limited Announces Dividend for the Fiscal Year 2022-2023 CI
Smruthi Organics Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022 CI
Smruthi Organics Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022 CI
Smruthi Organics Limited Approves the Dividend for the Year Ended March 31, 2022 CI
Smruthi Organics Limited Reports Earnings Results for the First Quarter Ended June 30, 2022 CI
Smruthi Organics Limited Recommends Dividend CI
Smruthi Organics Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2022 CI
Smruthi Organics Limited Approves Board Changes CI
Smruthi Organics Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2021 CI
Smruthi Organics Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2021 CI
Smruthi Organics' : Net Profit Slides in Fiscal Q1 MT
Smruthi Organics Limited Declares Dividend for the Year Ended 31 March 2021 CI
Smruthi Organics Limited Reports Earnings Results for the First Quarter Ended June 30, 2021 CI
Smruthi Organics Limited Recommends Dividend, Payable on or Before August 14, 2021 CI
Smruthi Organics Limited Recommends Dividend for the Year Ended March 31, 2021 CI
Smruthi Organics Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2021 CI
Smruthi Organics Limited Reports Earnings Results for the Third Quarter Ended December 31, 2020 CI
Smruthi Organics Limited Reports Earnings Results for the Second Quarter Ended September 30, 2020 CI
Chart Smruthi Organics Limited
More charts
Smruthi Organics Limited is an India-based active pharmaceutical ingredients (API) manufacturer serving pharmaceutical companies. The Company’s segments include Bulk Drugs and Drugs Intermediates and Formulation. It manufactures API products in the anti-diabetic, anti-hypertension and anti-infectives therapeutic categories. Its products include Amlodipine Besilate, Losartan Potassium, Telmisartan, Metformin HCL, S-Amlodipine Besilate, S-Amlodipine Malelate, Valsartan, Vildagliptin, Teneligliptin, Ciprofloxacin HCL, Diloxanide Furoate, Norfloxacin, Pefloxacin Mesylate, Ticagrelor, and others. It caters to both the Indian domestic as well as the rest of the world (ROW) markets, with clients spanning Asia, the Americas, and Africa. The Company has two manufacturing facilities in Solapur, India. The API facility is spread across 22-acre land.
More about the company
  1. Stock Market
  2. Equities
  3. SMRUTHIORG6 Stock
  4. News Smruthi Organics Limited
  5. Smruthi Organics' : Net Profit Slides in Fiscal Q1
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW